Blog

T cells

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply chains, today announce a non-exclusive collaborative partnership.

Read More
October 7, 2020

Vineti at Cell and Gene Meeting on the Mesa 2020

Next week marks the start of a very important annual event in advanced therapies — the Alliance for Regenerative Medicine’s...

October 7, 2020

Crispr’s Nobel Moment

“Crispr — overrated or underrated?” At this month’s CBInsights Future of Health conference, I had the good fortune to do a live...

August 25, 2020

OncoBay Clinical and Vineti form strategic alliance to deliver integrated clinical trial solutions and supply chain automation for cell and gene therapies

Integrated Custom-Curated IO Clinical Trial Services and Personalized Therapy Management systems to seamlessly manage advanced therapy clinical journeys for cancer...

August 17, 2020

Vineti Announces New Chief Commercial Officer

Proven biotech/pharma executive and advanced therapies pioneer Joe DePinto brings extensive commercial expertise to the industrialization of cell and gene...

August 17, 2020

Q&A: five questions for Joe DePinto

Today, Vineti is thrilled to announce that Joe DePinto has joined us as our Chief Commercial Officer. Joe is a long-time leader in...

August 13, 2020

Vineti Inc. named to the 2020 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups

Vineti Inc. named to the 2020 CB Insights Digital Health 150 — List of Most Innovative Digital Health StartupsVineti Inc....

August 11, 2020

Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing health disorders with no cure

Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing debilitating conditions NEWARK, Del. and SAN...

July 29, 2020

Vineti and EVERSANA™ form strategic alliance to advance patient-centered services and supply chain automation for regenerative medicine

Integrated Commercial Services and Personalized Therapy Management systems to seamlessly track product and patient journey SAN FRANCISCO, Calif. and CHICAGO,...

June 16, 2020

Announcing our new enterprise-grade Alliance Network — and a collaboration with Mavens — to further industrialize cell and gene therapies

Today, I’m really excited to share more progress from Vineti. We’ve launched the new Vineti Alliance Network to deliver an enterprise-grade approach...

June 8, 2020

Team Vineti stands in solidarity with the Black community: Black Lives Matter

Our company was founded in 2016 to bring life to the following vision: “Vineti works to create a world where individualized,...

May 29, 2020

Amy DuRoss selected for San Francisco Business Times’ Most Influential Women of 2020

Today, we’re proud to congratulate our CEO and Co-founder, Amy DuRoss, for her selection to the prestigious San Francisco Business Times’...

May 28, 2020

Cell and gene therapy — a dose of good news

Cancer, serious genetic disorders, and other pressing health conditions never stop. Neither does cell and gene therapy. And that’s great...